Navigation Links
Acomplia in Medical News

Sanofi-aventis Delivers 2008 Results Above Guidance

...iven by the adjuvant indication. In the "Other Countries" region, the product reported robust growth of 13.4% to EUR 186 million. Net sales of acomplia (R) , which was withdrawn from the market in the fourth quarter, totaled EUR 72 million in 2008. Worldwide presence(1) of Plavix (R) / Is...

Obesity Drug Shows Mixed Success Against Atherosclerosis

... Hope is that acomplia might help fight coronary disease TUES..., April 1 (HealthDay News) -- The weight-loss drug acomplia may or may not help slow atherosclerosis, a buildu...in one measure of plaque build-up in arteries. acomplia also showed a high rate of psychiatric side effect...

Drug Treatment Market For Obesity Will Increase More Than Five-Fold, Reaching $2.7 Billion in 2016

...nditions such as obesity poses one of the most significant threats to companies developing anti-obesity drugs. For example, although Sanofi- Aventis's acomplia (rimonabant) had been widely anticipated to become a key therapy for obesity, its blockbuster potential was eliminated after a negative opinion of the...

Pain receptor in brain may be linked to learning and memory

...e other implication may be cautionary. Drug makers already sell drugs such as the weight-loss pill rimonabant, which is sold in Europe under the name acomplia that can block TRPV1 receptors. Other drugs aimed at reducing pain and inflammation by blocking or activating TRPV1 receptors are in the research pip...

Possible Reason for Rimonabant's Side Effects Discovered

...1 at all," Kauer said. "However, in some patients, acomplia could be hitting TRPV1 and may well have an effect on activating this receptor," she said. acomplia is used widely outside the United States. To date,...U.S. Food and Drug Administration has not approved acomplia because of its psychiatric side effects. In add...

Pipeline for New Obesity Therapies is Focus of New Report

...anisms, including follow up approaches after orlistat, and novel approaches such as SGLT inhibition. Key drugs discussed in this report include: acomplia (rimonabant; Sanofi-Aventis), taranabant (MK-0364; Merck), CP-945598 (Pfizer), SLV 319 (BMS-646256; Solvay / BMS), rosonabant (E-6776; Esteve), AVE-16...

EU Drug Regulator Highlights Depression Danger of Weight-loss Pill

... The European drug regulator EMEA said Thursday it had maintained authorisation of weight-loss pill acomplia in the European Union, but had ordered it to be withheld from people suffering from depression. A panel of experts from the US Food and Drug ...

UK Reports Psychiatric Reactions to Weight-loss Drug Rimonabant

... said evidence suggested one in 10 people who take acomplia may develop psychiatric side effects. "Approx...monabant since it was launched there in June 2006. acomplia is manufactured by Sanofi-aventis, worlds fourth l...carry a warning "that doctors should not prescribe acomplia in patients with uncontrolled serious psychiatric ...

Sanofi Withdraws Anti-obesity Drug in US

... French pharmaceutical group Sanofi-Aventis said Friday it had withdrawn an application for regulatory approval for its anti-obesity drug acomplia in the United States. A panel of experts from the US Food and Drug Administration concluded earlier this month that the dieting treatment, re...

Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned

...tself, reports an article in the June issue of Drug and Therapeutics Bulletin (DTB). Advertisements for rimonabant (sold under the brand name acomplia by Sanofi-Aventis) claim that an estimated 50% of the effects on cardiometabolic risk factors are beyond those expected from weight loss alone. But D...
Acomplia in Medical Technology

Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success

...anofi-Aventis’ first-in-class CB1 antagonist acomplia (rimonabant) has at least five competitors in clin... and many more in earlier phases of R&D. While acomplia received EU approval in June 2006, the FDA request.... However, some countries such as Germany consider acomplia as a non-reimbursable life-style drug. Sanofi-Aven...
Other Tags
(Date:5/2/2015)... (PRWEB) May 02, 2015 Ticket Down has ... for the long awaited event today, Saturday, May 2nd ... Diehard boxing fans will be able to secure tickets for ... The fight that boxing fans have wanted for more than ... ago. Floyd “Money” Mayweather will step inside the ring to ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 “ ActOn ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... to get connected with organizations to make a difference. , ... are very few things that aren’t about money, which is ...
(Date:5/2/2015)... York, NY (PRWEB) May 02, 2015 ... when a deadly natural disaster strikes anywhere on this ... to leverage human sympathy and compassion for their own ... (United States Computer Emergency Readiness Team) issued an ... users “of potential email scams citing the earthquake in ...
(Date:5/2/2015)... 2015 “ Peachtree Audio ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... , Music is an important part of people’s ... and given the royal treatment. Peachtree Audio does just ...
(Date:5/2/2015)... 2015 Kare Visits LLC. launched in Chicago ... caregivers. Kare Visits offers relief for caregivers by visiting ... According to the Caregiver Action Network, eight in ... 20 hours a week caring for an elderly or disabled ... hire a nurse, a caregiver is now empowered to schedule ...
Breaking Medicine News(10 mins):Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Chicagoan Seeks to Transform Industry by Launching an Innovative Elderly Care Solution 2
(Date:4/17/2015)... , April 17, 2015 ... concerns, and technological advancement to drive biometric systems ... until 2020   According to a ... Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... to register growth at CAGR of over 22% ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading cloud-based ... to more fully engage with their communities around health ... privacy protected and secure API.  ... the most accessible, affordable, and convenient vehicle to receive ... The API will allow higi,s ...
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
Other Contents